Cargando…
Cerebral Venous Thrombosis after SARS-CoV-2 Infection and Pfizer-BioNTech Vaccination against COVID-19
In the last 3 years, COVID-19 pandemic has produced great impacts on global population in terms of health and social costs. Pneumonia represents only one of several pathologies associated to COVID-19 disease. Among these, the cerebral venous thrombosis (CVT), constitutes an important cause of stroke...
Autores principales: | Nicolardi, Martina, Urso, Daniele, Luceri, Silvia, Logroscino, Giancarlo, De Blasi, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140082/ https://www.ncbi.nlm.nih.gov/pubmed/35626407 http://dx.doi.org/10.3390/diagnostics12051253 |
Ejemplares similares
-
Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine
por: Qureshi, Muhammad Imran Ahmad, et al.
Publicado: (2022) -
Cerebral Venous Sinus Thrombosis After Pfizer-BioNTech COVID-19 (BNT162b2) Vaccination
por: Cheng, Newman
Publicado: (2021) -
COVID-19 Vaccine Pfizer BioNTech: Soreness at injection site and cerebral venous sinus thrombosis: case report
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Pulmonary embolism and deep venous thrombosis: case report
Publicado: (2022) -
COVID-19-Vaccine-Pfizer-BioNTech: Venous thromboembolism: case report
Publicado: (2022)